About IDM Pharma
IDM Pharma is a company based in Irvine (United States) founded in 1990 was acquired by Takeda in May 2009. IDM Pharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$12.5 M (USD), Post-IPO
Feb 21, 2007
-
Investors
Takeda Pharmaceuticals
& 2 more
-
Employee Count
Not available
-
Acquired by
Takeda
(May 18, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IDM Pharma
Investors in IDM Pharma
IDM Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Takeda Pharmaceuticals, Palo Alto Investors and Alta Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector investments are managed through private equity strategies.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on healthcare companies
|
Locked | Locked | Locked | |
|
Takeda Pharmaceuticals is engaged in developing innovative medicines globally.
|
Locked | Locked | Locked |
Investor details for IDM Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IDM Pharma
Investment portfolio details for IDM Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IDM Pharma
Detailed financials for IDM Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Idm Pharma Comparisons
Peer comparison for IDM Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IDM Pharma
IDM Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of IDM Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Idm Pharma
Complete news archive for IDM Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IDM Pharma
IDM Pharma was founded in 1990 and raised its 1st funding round 17 years after it was founded.
IDM Pharma is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
IDM Pharma was founded in 1990 and headquartered in Irvine, United States, within the biotechnology sector. Focus was placed on developing immunotherapies for cancer treatment. MEPACT (mifamurtide) was advanced for osteosarcoma and received approval in Europe prior to the 2007 acquisition by Takeda. Development of Bexidem for bladder cancer was subsequently halted. Operations centered on innovative therapeutic solutions in oncology.
IDM Pharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
IDM Pharma has 3 investors. Key investors include Takeda Pharmaceuticals, Palo Alto Investors, and Alta Partners.